Comments on: Reverse Pharmacology in Ayurveda: How Bedside-to-Bench Validation Is Changing Herbal Medicine

By: Paul Anderson

Paul Anderson — Fri, 04 Sep 2026 15:00:25 +0000

at which Samprapti stage does the disease become difgicult to reverse? is Vyakti the point of no return or does Bheda cross that line?

By: Priyanka Goyal

Priyanka Goyal — Sat, 29 Aug 2026 08:14:05 +0000

samprapti stages are clinically useful but the attribution of specific diseases to apecific stages is overly rigid in practice.

By: Laura Allen

Laura Allen — Mon, 24 Aug 2026 14:00:21 +0000

In reply to Nandini Pandey. @Nandini samprapti stages are clinically useful but the attribution of specific diseases to specific stages is overly rigid in practice.

By: Nandini Pandey

Nandini Pandey — Sun, 23 Aug 2026 15:18:26 +0000

understanding Samprapti aa a sequence rather than a fixed state changed how I think about treatment timing. early stages are so much more tractable.

By: Paul Baker

Paul Baker — Sun, 23 Aug 2026 14:40:45 +0000

@Ravi how does the Samprapti Ghatakas model handle autoimmune conditions where the body’s own tissues become the ‘enemy’?

By: Christopher Menon

Christopher Menon — Thu, 20 Aug 2026 14:56:31 +0000

Makes sense.

By: Ashley Carter

Ashley Carter — Thu, 20 Aug 2026 09:43:33 +0000

Applying omics to reverse pharmacology sounds promising, especially for mapping how multi target herbs shift disease networks.

By: Rebecca Smith

Rebecca Smith — Wed, 19 Aug 2026 20:15:36 +0000

how does the Samprspti Ghatakas model handle autoimmune conditions where the body’s own tissues become the ‘enemy’?

By: Jason Miller

Jason Miller — Mon, 17 Aug 2026 06:00:42 +0000

The survivorship bias note is a good reminder that long standing herbs aren’t automatically the most potent, just the most culturally persistent.

By: Jessica Smith

Jessica Smith — Sat, 15 Aug 2026 23:09:39 +0000

how does the Samorapti Ghatakas model handle autoimmune conditions where the body’s own tissues become the ‘enemy’? tbh